0001209191-12-009621.txt : 20120213 0001209191-12-009621.hdr.sgml : 20120213 20120213180345 ACCESSION NUMBER: 0001209191-12-009621 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110822 FILED AS OF DATE: 20120213 DATE AS OF CHANGE: 20120213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Polymeropoulos Mihael Hristos CENTRAL INDEX KEY: 0001355537 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34186 FILM NUMBER: 12600891 MAIL ADDRESS: STREET 1: 9605 MEDICAL CENTER DRIVE SUITE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vanda Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001347178 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030491827 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9605 MEDICAL CENTER DRIVE STREET 2: SUITE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-599-4500 MAIL ADDRESS: STREET 1: 9605 MEDICAL CENTER DRIVE STREET 2: SUITE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0304 4/A 2011-08-22 2011-08-24 0 0001347178 Vanda Pharmaceuticals Inc. VNDA 0001355537 Polymeropoulos Mihael Hristos 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 1 1 0 0 President and CEO Common Stock 2011-08-22 4 P 0 2080 5.3423 A 400830 D Common Stock 2011-08-23 4 P 0 7920 5.3476 A 408750 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.33 to $5.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4. The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 382,080 shares. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.34 to $5.35, inclusive. The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 390,000 shares. /s/ Mihael H. Polymeropoulos 2012-02-13